Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

p> REMERON c/ 33 - N/M 33 - N/M

ZEMURON c/ 25 - N/M 25 - N/M

LIVIAL c/ 24 - N/M 24 - N/M

CERAZETTE c/ 20 - N/M 20 - N/M

MARVELON c/ 20 - N/M 20 - N/M

MERCILON c/ 18 - N/M 18 - N/M

IMPLANON c/ 15 - N/M 15 - N/M

Other

Pharmaceuticals 610 400 53% 1,795 1,609 12%

CONSUMER HEALTH CARE 254 205 24% 1,266 1,123 13%

OTC 161 118 37% 682 558 22%

OTC CLARITIN 94 72 30% 462 390 18%

Foot Care 74 73 1% 345 343 1%

Sun Care 19 14 38% 239 222 8%

ANIMAL HEALTH b/ 507 234 117% 1,251 910 37%

CONSOLIDATED GAAP

NET SALES $3,724 $2,650 41% $12,690 $10,594 20%

a/ Global Pharmaceuticals net sales for both the three and twelve months

ended December 31, 2007, include $409 million from Organon, the human

health business of Organon BioSciences. Sales of Organon are reflected

as of the closing date of the acquisition on November 19, 2007 through

year-end.

b/ Animal Health net sales for both the three and twelve months ended

December 31, 2007, include $217 million from Intervet, the animal

health business of Organon BioSciences. Sales of Intervet are

reflected as of the closing date of the acquisition on November 19,

2007 through year-end.

c/ Products acquired in OBS acquisition reflect net sales for the period

from November 19, 2007 through year-end.

NOTE: Additio
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)... , a precision medicine software company that has developed a ... genomic, imaging and other biomedical data in research and clinical ... CEO of Aspera, an IBM Company, to its board as ... "We are pleased to welcome Michelle to ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 PlasmaTech ... care in critical areas, announced the closing of an underwritten ... to purchase up to an aggregate 3,500,000 shares of common ... $.01 per warrant.  The warrants have a per share exercise ...
(Date:12/24/2014)... Missouri (PRWEB) December 23, 2014 GMO corn ... company, Syngenta, are in the process of being consolidated in ... is In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... of Kansas. , Management of the Syngenta GMO corn multidistrict ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... and GridGain System partnered up in delivering industry first dedicated solution ... The integration between GridGain,s Open Cloud Platform and Inventigo,s FastXML product ... near real-time fashion. , ... San Francisco, CA (PRWEB) ...
... and Endpoints in both Chemotherapy Naive and Post-Chemotherapy Patients ... Cancers Symposium -- Medivation to Host Conference Call and ... p.m. Eastern Time - SAN FRANCISCO, Feb. 25 ... the presentation of new efficacy and safety data from ...
... /PRNewswire/ - How does a Science Cluster work? Vineland ... with its model for the future. , "Vineland will ... Canada, industry will steer the direction and government will ... Research and Innovation Centre. "And as we execute on ...
Cached Biology Technology:Inventigo and GridGain Systems Team Up on Delivering Cloud-Enabled High Performance XML Processing 2Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 5Vineland Enables Industries' Efforts to Build Agri-Science Research Cluster 2
(Date:1/22/2015)... and POINT ROBERTS, Washington , January 20, ... leading sectors including technology and tech stocks, releases video from ... master pickpocket and security consultant Apollo Robbins . ... talks about the Wocket™ biometric smart wallet, a product of ...
(Date:1/22/2015)... January 22, 2015 , ... The European Patent Office to present a video retrospective ... nominations to be featured: Christofer Toumazou and Sophie ... finalists and winners of the Award   Starting on ...
(Date:1/22/2015)... Jan. 22, 2015   EyeLock, Inc. , a market leader ... Steve Gerber to the new role of Senior ... for leading development of mobile platforms and wearable solutions for ... and innovation in the semiconductor industry to his role at ...
Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... most biofuels crops, including corn, rapeseed and wheat, have ... suggesting many countries need to reset their expectations of ... according to a study led by Matt Johnston and ... for Environmental Studies and Jon Foley of University of ...
... new application of photoacoustic tomography (PAT) is worth its ... For the first time, Lihong Wang, Ph.D., Gene ... Engineering, with a joint appointment in Radiology, and Younan ... with a joint appointment in chemistry in Arts & ...
... the University of Pittsburgh School of Medicine have successfully ... replicate robustly in a living animal, as well as ... models and methods for studying diabetes, but also opens ... scientists thought that these important pancreatic cells could not ...
Cached Biology News:Nations that sow food crops for biofuels may reap less than previously thought 2Nations that sow food crops for biofuels may reap less than previously thought 3Novel technique changes lymph node biopsy, reduces radiation exposure 2Human beta cells can be easily induced to replicate, according to study in Diabetes 2
...
Request Info...
... , Maintenance 112 days/each , ... Immunizations/Boost injections x5 /each , ... , Production bleed (25 ml blood =12 ml ... ml blood (~50 ml serum) x1 each , ...
FluoSpheres® biotin-labeled microspheres, 1.0 µm, yellow-green fluorescent (505/515) *1% solids*...
Biology Products: